JSC Gedeon Richter is one of the largest pharmaceutical manufacturers in Eastern Europe. The company has mastered the production of 200 types of drugs, a fifth of which are its own unique developments.
The path to success
The first Gedeon Richter pharmacy opened in 1901 in Budapest, Hungary. At that time, pharmacists themselves prepared medicinal drugs. A laboratory was equipped at the pharmacy, where the production of organotherapeutic drugs produced from extracts of the glands of cattle was organized.
After 6 years, the first plant was launched, the production of lecithins, vitamins and other components was launched. Later, they mastered the processing of plant materials: digitalis preparations, derivatives of salicylic acid, appeared. By the way, the drug "Calmopyrin", mastered in 1912, is still used today. By 1914, Gedeon Richter had patented 24 drugs, becoming a strategic pharmaceutical enterprise in Austria-Hungary.
The pill that changed the world
With the beginning of the "era of contraception" in the 60s, many associate such a phenomenon as a significant change in the social status of women in society. Contraceptives allowed 100%prevent unplanned pregnancy.
It was the outstanding pharmacist from Budapest, Gedeon Richter, who stood at the origins of hormonal synthesis and worked on the first contraceptive pill. The production of gynecological preparations was started from the very foundation of the company in 1901, together with the development of the first organotherapeutic preparations. In 1939, the company developed a technology for isolating estrone, and set up industrial production of crystalline estrone. The creation of synthetic testosterone and progesterone consolidated the success.
Gedeon Richter: preparations
In the 1950s, a key compound for hormone synthesis was created, used to produce sex hormones (progesterone, estrone, and testosterone), non-steroidal anabolic agents, and oral contraceptives.
From the early 1960s, Gedeon Richter began to use the most modern production technologies, including sterile fermentation. In the future, thanks to new technologies, it became possible to manufacture new active substances, such as norgestrel, levonorgestrel and their derivatives, as a result of which the combined hormonal contraceptive was created, released in 1966. The company also brought hormonal contraception to the USSR for the first time.
Now there are drugs of the fourth generation, which, for example, contain drospirenone as an active ingredient. Being a synthetic hormone, it is similar to the progesterone produced by the body.
Quality
Important in the production of hormonal drugshave production control and compliance with all advanced standards. Simply put, it is important to understand exactly how and under what technological conditions hormonal preparations are synthesized in order to boldly talk about the quality of the product and minimize undesirable effects. In the world, a few large concerns have their own synthesis of sex steroids. The pharmaceutical industry is armed with high-performance liquid chromatography, nuclear magnetic resonance and other high-tech assistants.
Substances for the manufacture of drugs and the hormonal components themselves are produced in Hungary, which allows you to trace all stages of production and be sure of the result. It is this quality and approach that doctors and patients, as well as scientists from the countries where the company supplies its famous substances, trust.
Development
Today, intellectual capital is a key factor in determining the weight of a company, so leading companies need to invest in R&D (research and development). For the pharmaceutical business, this means that research and development activities in the field of developing new products and practical solutions become the core of development. It is noteworthy that Gedeon Richter is the only Eastern European firm to enter the TOP-200 in the innovation spending category with 12% of annual turnover.
In 2010, the joint-stock company bought out the Swiss biopharmaceutical firm Preglem. She proposes molecules for the treatment of complex gynecological diseases such asuterine fibroids, endometriosis and others.
Gedeon Richter-Rus
The company produces about two hundred types of medicines in more than 400 forms of release. As part of the strategy for the future, it was decided in 1996 to establish a separate production facility in Central Russia. Hungarian pharmacists built one of the five subsidiaries in the Yegoryevsky district near Moscow. It releases:
- prepared medicines;
- intermediates;
- active substances.
Thus, Gedeon Richter-Rus became the first foreign pharmaceutical company in Russia. Today, the plant provides not only the domestic market, but also exports medicines to the CIS countries (Georgia, Armenia, Moldova, Azerbaijan).
For the benefit of society
The current situation involves the joint work of scientists - pharmacists and doctors for the benefit of society. Gedeon Richter initiates and supports various events in Russia:
- scientific and practical conferences;
- seminars, congresses;
- international forums.
The task of preserving women's reproductive he alth should be addressed at all levels. Following this logic, Gedeon Richter regularly carries out educational and other supportive activities for the professional community. For example, Hungarian pharmacists have been sponsoring the Reproductive Tomorrow of Russia award for many years. The award winners make an invaluable contribution to the development of the Russian school of obstetrics and gynecology.
"Gedeon Richter" has a scientific base at the level of the highest world standards, its own scientific developments have allowed the company to significantly expand the range of gynecological drugs. A wide selection helps professionals and women make important decisions in their lives, while the quality and assortment of hormonal contraceptives continues to improve.
